TipRanks
Parabilis Medicines, Inc. (PBLS)
NASDAQ:PBLS
US Market
PBLS
Parabilis Medicines, Inc.
RESEARCH TOOLSreports
Want to see PBLS full AI Analyst Report?

Parabilis Medicines, Inc. (PBLS) Income Statement

34 Followers

Parabilis Medicines, Inc. Income Statement

Last quarter (Q2 2026), Parabilis Medicines, Inc.'s total revenue was $148.00K, an increase of Infinity% from previous quarter. In Q2, Parabilis Medicines, Inc.'s net income was $-52.46M. See Parabilis Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 152.08M$ 126.13M
Depreciation and Amortization
$ 2.50M$ 2.10M
EBITDA
$ -141.87M$ -114.33M
Operating Income
$ -152.08M$ -126.13M
Other Income/Expenses
$ 6.19M$ 8.21M
Pretax Income
$ -145.89M$ -117.91M
Net Income
$ -145.89M$ -117.91M
Per Share Metrics
Basic EPS
$ -92.40$ -83.48
Diluted EPS
$ -92.40$ -83.48
Weighted Average Shares Outstanding
 2.02M 1.93M
Weighted Average Shares Outstanding (Diluted)
 2.02M 1.93M
Currency in USD

Parabilis Medicines, Inc. Earnings and Revenue History